Integration of palliative care into the neuro-oncology practice: Patterns in the United States

Neuro-Oncology Practice

Volumn 1, Issue 1, 2014, Pages 3-7

  Walbert, Tobias ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

End of life; Glioblastoma; Glioma; Palliative care; Supportive care

Indexed keywords

ARTICLE; BRAIN TUMOR; CLINICAL DECISION MAKING; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DROWSINESS; DYSPHAGIA; GLIOBLASTOMA; GLIOMA; HEADACHE; LIFE EXPECTANCY; LUNG METASTASIS; NEUROLOGIC DISEASE; NON SMALL CELL LUNG CANCER; PALLIATIVE THERAPY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEIZURE; TERMINAL CARE; UNITED STATES; WEAKNESS;

EID: 84976341625     PISSN: 20542577     EISSN: 20542585     Source Type: Journal    
DOI: 10.1093/nop/npt004     Document Type: Article

References (33)

1. Clark D. From margins to centre: a review of the history of palliative care in cancer. Lancet Oncol. 2007;8(5):430-438.
2. World Health Organization: Programmes and Projects: Cancer Control. Policies and Managerial Guidelines. http://www.who.int/cancer/palliative/definition/en/s. Accessed 10/12/2013.
3. Dalal S, Palla S, Hui D, et al. Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist. 2011;16(1): 105-111.
4. Fadul N, Elsayem A, Palmer JL, et al. Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer. 2009;115(9): 2013-2021.
5. Maciasz RM, Arnold RM, Chu E, et al. Does it matter what you call it? A randomized trial of language used to describe palliative care services. Support Care Cancer. 2013;21(12):3411-3419.
6. Fallon M, Smyth J. Terminology: the historical perspective, evolution and current usage-room for confusion? Eur J Cancer. 2008;44(8): 1069-1071.
7. Goldsmith B, Dietrich J, Du Q, et al. Variability in access to hospital palliative care in the United States. J Palliat Med. 2008;11(8): 1094-1102.
8. Hui D, Elsayem A, De la Cruz M, et al. Availability and integration of palliative care at US cancer centers. JAMA. 2010;303(11): 1054-1061.
9. Mount BM. The problem of caring for the dying in a general hospital; the palliative care unit as a possible solution. Can Med Assoc J. 1976; 115(2):119-121.
10. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
11. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008; 359(5):492-507.
12. Prados MD, Seiferheld W, Sandler HM, et al. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Int J Radiat Oncol Biol Phys. 2004;58(4): 1147-1152.
13. van den Bent MJ, Carpentier AF, Brandes AA, et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol. 2006;24(18):2715-2722.
14. Minniti G, Scaringi C, Baldoni A, et al. Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide. Int J Radiat Oncol Biol Phys. 2013;86(27):285-291.
15. Armstrong TS, Wefel JS, Wang M, et al. Net clinical benefit analysis of radiation therapy oncology group 0525: A phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol. 2013;31(32):4076-4084.
16. Meier DE, Brawley OW. Palliative care and the quality of life. J Clin Oncol. 2011;29(20):2750-2752.
17. Walbert T, Glantz M, Schultz L, et al. Utilization patterns of palliative care in neuro-oncology-results of an international provider survey, Poster #0359. Paper presented at: 4th Quadrennial Meeting of the World Federation of Neuro-Oncology held in conjunction with the 2013 Scientific Meeting and Education Day of the Society for Neuro-Oncology. 2013; San Francisco, CA.
18. Bruera E, Hui D. Conceptual models for integrating palliative care at cancer centers. J Palliat Med. 2012;15(11):1261-1269.
19. Bruera E, Hui D. Integrating supportive and palliative care in the trajectory of cancer: establishing goals and models of care. J Clin Oncol. 2010;28(25):4013-4017.
20. Greer JA, Jackson VA, Meier DE, et al. Early integration of palliative care services with standard oncology care for patients with advanced cancer. Cancer J Clinic. 2013;63(5):349-363.
21. Arber A, Faithfull S, Plaskota M, et al. A study of patients with a primary malignant brain tumour and their carers: symptoms and access to services. Int J Palliat Nurs. 2010;16(1):24-30.
22. Gofton TE, Graber J, Carver A. Identifying the palliative care needs of patients living with cerebral tumors and metastases: a retrospective analysis. J Neurooncol. 2012;108(3):527-534.
23. Oberndorfer S, Lindeck-Pozza E, Lahrmann H, et al. The end-of-life hospital setting in patients with glioblastoma. J Palliat Med. 2008; 11(1):26-30.
24. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733-742.
25. Fraser LK, van Laar M, Miller M, et al. Does referral to specialist paediatric palliative care services reduce hospital admissions in oncology patients at the end of life?. Br J Cancer. 2013;108(6): 1273-1279.
26. Bausewein C, Hau P, Borasio GDI, et al. How do patients with primary brain tumours die?. Palliat Med. 2003;17(6):558-559.
27. Faithfull S, Cook K, Lucas C. Palliative care of patients with a primary malignant brain tumour: case review of service use and support provided. Palliat Med. 2005;19(7):545-550.
28. Pace A, Di Lorenzo C, Lorenzo CD, et al. End of life issues in brain tumor patients. J neurooncol. 2009;91(1):39-43.
29. Pace A, Villani V, Di Lorenzo C, et al. Epilepsy in the end-of-life phase in patients with high-grade gliomas. J Neurooncol. 2013;111(1):83-86.
30. Sizoo EM, Braam L, Postma TJ, et al. Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro Oncol. 2010; 12(11):1162-1166.
31. Walbert T, Khan M. End-of-life symptoms and care in patients with primary malignant brain tumors: A systematic literature review. J Neuro Oncol. 2014; In Press.
32. Teunissen SC, WeskerW, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007;34(1):94-104.
33. Sizoo EM, Pasman HR, Buttolo J, et al. Decision-making in the end-of-life phase of high-grade glioma patients. Eur J Cancer. 2012;48(2):226-232.